Inna Dolzhikova - National Research Center for Epidemiology and Microbiology, Federal State Budget Institution

基本信息

浏览量：2

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 66 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Structural Basis for Evasion of New SARS-CoV-2 Variants from the Potent Virus-Neutralizing Nanobody Targeting the S-Protein Receptor-Binding Domain

Nikolai N. Sluchanko,Dmitry V. Shcheblyakov,Larisa A. Varfolomeeva,Irina A. Favorskaya,Inna V. Dolzhikova, Anastasia I. Korobkova,Irina A. Alekseeva,Ilias B. Esmagambetov,Artem A. Derkaev,Vladimir V. Prokofiev, Ilya D. Zorkov,Denis Y. Logunov,Alexander L. Gintsburg,Vladimir O. Popov,Konstantin M. Boyko

Biochemistry (Moscow)no. 7 (2024): 1260-1272

引用0浏览0WOS引用

New Conjugates Based on N4-hydroxycytidine with More Potent Antiviral Efficacy in Vitro Than EIDD-2801 Against SARS-CoV-2 and Other Human Coronaviruses

Andrei E. Siniavin,Vladimir A. Gushchin,Natal 'ya S. Shastina, Elizaveta S. Darnotuk,Sergey I. Luyksaar,Leonid I. Russu, Anna M. Inshakova,Elena Shidlovskaya,Daria V. Vasina,Nadezhda A. Kuznetsova, Daria M. Savina, Ilya D. Zorkov,Inna Dolzhikova,Anna B. Sheremet,Denis Y. Logunov,Nailya A. Zigangirova,Alexander L. Gintsburg

ANTIVIRAL RESEARCH (2024)

引用0浏览0WOS引用

Immunogenicity and Protectivity of Sputnik V Vaccine in Hace2-Transgenic Mice Against Homologous and Heterologous SARS-CoV-2 Lineages Including Far-Distanced Omicron BA.5

Inna V. Dolzhikova,Amir I. Tukhvatulin,Daria M. Grousova, Ilya D. Zorkov, Marina E. Komyakova, Anna A. Ilyukhina,Anna V. Kovyrshina,Artem Y. Shelkov,Andrey G. Botikov, Ekaterina G. Samokhvalova, Dmitrii A. Reshetnikov, Andrey E. Siniavin, Daria M. Savina, Dmitrii V. Shcheblyakov, Fatima M. Izhaeva,Alina S. Dzharullaeva,Alina S. Erokhova,Olga Popova, Tatiana A. Ozharovskaya,Denis I. Zrelkin, Polina P. Goldovskaya, Alexander S. Semikhin,Olga V. Zubkova,Andrey A. Nedorubov,Vladimir A. Gushchin,Boris S. Naroditsky,Denis Y. Logunov, Alexander L. Gintsburg

VACCINESno. 10 (2024)

引用0浏览0WOS引用

≪i>in Vitro</i> Antiviral Activity of a New Indol-3-carboxylic Acid Derivative Against SARS-CoV-2

A. N. Narovlyansky,М. В. Филимонова,N. G. Tsyshkova,А. В. Пронин,Т. В. Гребенникова, Э. В. Карамов,В. Ф. Ларичев, G. V. Kornilayeva,I. Т. Fedyakina,Inna V. Dolzhikova,М. В. Мезенцева,Е. И. Исаева,В. В. Полосков, Lauren E. Koval,V. P. Marinchenko,Valentina Surinova,А. С. Филимонов,Anna Shitova,O. V. Soldatova, А. В. Санин,I. K. Zubashev, Alexey Ponomarev,V. V. Veselovsky, В. И. Козлов, А. В. Степанов, А. В. Хомич, В. С. Козлов, С. А. Иванов,П. В. Шегай, А. Д. Каприн, Ф. И. Ершов, A. L. Gintsburg

Acta naturaeno. 4 (2024): 83-91

引用0浏览0引用

In Vitro Antiviral Activity of a New Indol-3-carboxylic Acid Derivative Against SARS- CoV-2

A. N. Narovlyansky, M. Filimonova,N. G. Tsyshkova,A. Pronin, T. Grebennikova, E. Karamov,V. F. Larichev, G. Kornilayeva,I. T. Fedyakina,I. Dolzhikova,M. Mezentseva,E. I. Isaeva,V. V. Poloskov, L. S. Koval,V. P. Marinchenko, V. Surinova,A. S. Filimonov,A. A. Shitova, O. Soldatova, A. Sanin,I. K. Zubashev, A. Ponomarev,V. V. Veselovsky, V. V. Kozlov, A. Stepanov, A. Khomich, V. S. Kozlov, S. A. Ivanov,P. Shegai,A. D. Kaprin,F. Ershov,A. L. Gintsburg

ACTA NATURAEno. 4 (2023): 83-91

引用0浏览0WOS引用

Production and Characterisation of a SARS-CoV-2 S-protein RBD Homodimer with Increased Avidity for Specific Antibodies

A. A. Derkaev,E. I. Ryabova,V. V. Prokofiev,I. A. Favorskaya,D. M. Grousova,I. B. Esmagambetov,I. V. Dolzhikova,D. V. Shcheblyakov

Biological Products Prevention, Diagnosis, Treatmentno. 1 (2023): 76-89

引用0浏览0引用

Lethality of West Nile virus strains in a mouse model

A.E. Siniavin,I.V. Dolzhikova,A.A. Pochtovyi, D.A. Reshetnikov,V.A. Gushchin

biorxiv（2023）

引用0浏览0引用

Raav Expressing Recombinant Antibody for Emergency Prevention and Long-Term Prophylaxis of COVID-19

Ilias B. Esmagambetov,Ekaterina I. Ryabova,Artem A. Derkaev,Dmitry V. Shcheblyakov,Inna V. Dolzhikova,Irina A. Favorskaya,Daria M. Grousova,Mikhail A. Dovgiy,Vladimir V. Prokofiev, Andrey I. Gosudarev, Daria V. Byrikhina, Ilia D. Zorkov,Anna A. Iliukhina,Anna V. Kovyrshina,Artem Y. Shelkov,Boris S. Naroditsky,Denis Y. Logunov,Alexander L. Gintsburg

Frontiers in Immunology（2023）

引用0浏览0WOS引用

In Vitro Efficacy of Antivirals and Monoclonal Antibodies against SARS-CoV-2 Omicron Lineages XBB.1.9.1, XBB.1.9.3, XBB.1.5, XBB.1.16, XBB.2.4, BQ.1.1.45, CH.1.1, and CL.1

Andrei A Pochtovyi,Daria D Kustova,Andrei E Siniavin,Inna V Dolzhikova,Elena V Shidlovskaya, Olga G Shpakova,Lyudmila A Vasilchenko, Arina A Glavatskaya,Nadezhda A Kuznetsova,Anna A Iliukhina,Artem Y Shelkov, Olesia M Grinkevich,Andrei G Komarov,Denis Y Logunov,Vladimir A Gushchin,Alexander L Gintsburg

Vaccinesno. 10 (2023): 1533-1533

引用0浏览0WOS引用

Real-world Clinical Effectiveness of Tixagevimab/Cilgavimab and Regdanvimab Monoclonal Antibodies for COVID-19 Treatment in Omicron Variant-Dominant Period

Daria S. Fomina,Marina S. Lebedkina,Anna A. Iliukhina,Anna V. Kovyrshina,Artem Y. Shelkov,Sergey S. Andreev,Anton A. Chernov,Inna V. Dolzhikova,Tatyana S. Kruglova,Gerelma V. Andrenova, Amir I. Tukhvatulin,Dmitry V. Shcheblyakov,Alexander V. Karaulov,Maryana A. Lysenko,Denis Y. Logunov,Alexander L. Gintsburg

Frontiers in immunology（2023）

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn